India · Delayed Price · Currency is INR Revance Therapeutics Statistics
Total Valuation
NSE:AJMERA has a market cap or net worth of INR 33.86 billion. The enterprise value is 40.46 billion.
| Market Cap | 33.86B |
| Enterprise Value | 40.46B |
Important Dates
The last earnings date was Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | Aug 2, 2024 |
Share Statistics
| Current Share Class | 39.36M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +6.54% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 8.95M |
Valuation Ratios
The trailing PE ratio is 25.50.
| PE Ratio | 25.50 |
| Forward PE | n/a |
| PS Ratio | 4.22 |
| PB Ratio | 2.56 |
| P/TBV Ratio | 2.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 30.47 |
| EV / Sales | 5.04 |
| EV / EBITDA | 16.53 |
| EV / EBIT | 16.77 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.76 |
| Debt / FCF | n/a |
| Interest Coverage | 3.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.94% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 26.32M |
| Profits Per Employee | 4.35M |
| Employee Count | 305 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:AJMERA has paid 482.30 million in taxes.
| Income Tax | 482.30M |
| Effective Tax Rate | 26.59% |
Stock Price Statistics
The stock price has increased by +15.02% in the last 52 weeks. The beta is 0.60, so NSE:AJMERA's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +15.02% |
| 50-Day Moving Average | 906.71 |
| 200-Day Moving Average | 917.70 |
| Relative Strength Index (RSI) | 37.98 |
| Average Volume (20 Days) | 128,100 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AJMERA had revenue of INR 8.03 billion and earned 1.33 billion in profits. Earnings per share was 34.95.
| Revenue | 8.03B |
| Gross Profit | 2.89B |
| Operating Income | 2.41B |
| Pretax Income | 1.81B |
| Net Income | 1.33B |
| EBITDA | 2.45B |
| EBIT | 2.41B |
| Earnings Per Share (EPS) | 34.95 |
Balance Sheet
The company has 1.33 billion in cash and 6.76 billion in debt, giving a net cash position of -5.43 billion.
| Cash & Cash Equivalents | 1.33B |
| Total Debt | 6.76B |
| Net Cash | -5.43B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 13.23B |
| Book Value Per Share | 306.40 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 36.04%, with operating and profit margins of 30.06% and 16.54%.
| Gross Margin | 36.04% |
| Operating Margin | 30.06% |
| Pretax Margin | 22.59% |
| Profit Margin | 16.54% |
| EBITDA Margin | 30.49% |
| EBIT Margin | 30.06% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -6.54% |
| Shareholder Yield | -6.07% |
| Earnings Yield | 3.92% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 11, 2009. It was a reverse split with a ratio of 0.3.
| Last Split Date | May 11, 2009 |
| Split Type | Reverse |
| Split Ratio | 0.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |